In a word, these results revealed that compound 6 could reduce the downstream protein levels of p-STAT3 and c-Myc by interfering with the interaction between Hsp110 and STAT3, thereby ameliorating pulmonary vascular remodeling in hypoxia-induced PAH rat models. The gene discussed is MYC; the disease is pulmonary arterial hypertension.